Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on SUCAMPO PHARMACEUTICALS, I
5d ago SUCAMPO PHARMACEUTICALS, INC.: Sucampo to be Added to the NASDAQ Biotechnology ..
05/13 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Host Update on AMITIZ..
05/07 SUCAMPO PHARMACEUTICALS, INC.: Reports First Quarter 2013 Financial and Operati..
04/30 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces First Quarter ..
04/24 SUCAMPO PHARMACEUTICALS, INC.: And Revolution Lighting Technologies News (NASDA..
04/23 SUCAMPO PHARMACEUTICALS, INC.: FDA Approves Supplemental New Drug Application f..
03/29 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Present at 20th Annua..
03/14DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/14DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/13 SUCAMPO PHARMACEUTICALS, INC.: Reports Fourth Quarter and Full Year 2012 Financ..
03/06 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces Fourth Quarter..
03/04 SUCAMPO PHARMACEUTICALS, INC.: Sucampo and Festival Partnership Continues to Bl..
03/01 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Appoints Barbara A. Munder and Maureen E..
02/19 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Commercial Availability of RES..
02/08 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Files Patent Infringement Lawsuit Agains..
02/06 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Present at Investment..
02/04 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Japanese Government Funding fo..
01/03 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces Webcast of Its..
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces FDA Approval of an sNDA for RE..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Receives $15 Million Milestone Payment f..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Approval of a Supplemental App..
2012 SUCAMPO PHARMACEUTICALS, INC.: Reports Third Quarter and Nine Months 2012 Finan..
2012 SUCAMPO PHARMACEUTICALS, INC.: CORRECTING and REPLACING Sucampo Pharmaceuticals..
2012SUCAMPO PHARMACEUTICALS, INC.: quaterly earnings release
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces Third Quarter ..
2012 SUCAMPO PHARMACEUTICALS, INC.: U.S. Food and Drug Administration Grants Priorit..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Host Analyst Meeting ..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Appoints Glenn Noronha, ..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Receives U.K. Approval f..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces One-to-One Con..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Present at Investment..
2012 SUCAMPO PHARMACEUTICALS, INC.: Reports Second Quarter and Six Months 2012 Finan..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Second Quarter and Six Months ..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo and Takeda Announce Filing of Supplement..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Announces Arbitration De..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Webcast of its Presentation at..
2012 SUCAMPO PHARMACEUTICALS, INC.: CORRECTING and REPLACING Sucampo Pharmaceuticals..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Appoints Silvia Taylor, MBA, as Senior V..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Appoints Dipak Panigrahi, MS, MD, as Vic..
2012 SUCAMPO PHARMACEUTICALS, INC.: Change in Date of Anticipated Arbitration Decisi..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Presents Detailed Results of Positive Ph..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Presents Data for AMITIZAź in the Treatm..
2012 SUCAMPO PHARMACEUTICALS, INC.: Cobiprostone Preclinical Data from NSAID-Induced..
2012 SUCAMPO PHARMACEUTICALS, INC.: Reports First Quarter 2012 Financial and Operati..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces First Quarter 2012 Financial R..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Provides Update on Antic..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo and Clinigen Announce Named Patient Prog..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo and Clinigen Announce Named Patient Prog..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Webcast of its Presentation at..
2012 SUCAMPO PHARMACEUTICALS, INC.: Positive Top-Line Results from Phase 3 Long-term..
2012 SUCAMPO PHARMACEUTICALS, INC.: Reports Fourth Quarter and Full Year 2011 Financ..
2012 SUCAMPO PHARMACEUTICALS, INC.: Phase 3 Long-Term Safety Trial Results of Lubipr..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Fourth Quarter and Full Year 2..
2012 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Webcast of Its Presentation at..
2012 SUCAMPO PHARMACEUTICALS, INC.: Lubiprostone Meets Primary Endpoint in Phase 3 C..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Reports Conclusion of Arbitration Hearin..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Promotes Birgit Roerig, Ph.D. to Vice Pr..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals to Present at Upcoming H..
2011 SUCAMPO PHARMACEUTICALS, INC.: Reports Third Quarter 2011 and Year to Date Fina..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Appoints Cary J. Claiborne as Chief Fina..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Announces Third Quarter 2011 Financial R..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Pharmaceuticals Invites Investors to Lis..
2011 SUCAMPO PHARMACEUTICALS, INC.: Sucampo Names Greg Deener Vice President of Mark..
2011 SUCAMPO PHARM 'A': Sucampo Announces Stock Repurchase Program
2011 SUCAMPO PHARM 'A': Sucampo and Numab Sign Drug Discovery Collaboration
2011 SUCAMPO PHARM 'A': Sucampo Announces R&D Leadership Changes
2011 SUCAMPO PHARM 'A': Sucampo Appoints Daniel P. Getman, Ph.D. to its Board of Dir..
2011 SUCAMPO PHARM 'A': Sucampo Pharmaceuticals, Inc. Reports Second Quarter 2011 an..
2011 SUCAMPO PHARM 'A': Sucampo to Release Second Quarter and Year to Date 2011 Fina..
2011 SUCAMPO PHARM 'A': Sucampo to Release Second Quarter and Year to Date 2011 Fina..
2011 SUCAMPO PHARM 'A': Sucampo AG Names Peter Lichtlen, M.D., Ph.D., Senior Medical..
2011 SUCAMPO PHARM 'A': Sucampo Pharmaceuticals, Inc. Reports First Quarter 2011 Fin..
2011 SUCAMPO PHARM 'A': Phase 2 Clinical Trial Data of UF-021 in Retinitis Pigmentos..
2011 SUCAMPO PHARM 'A': Sucampo to Release First Quarter 2011 Financial Results and ..
1  2Next
Advertisement
Chart
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Income Statement Evolution
Sucampo Pharmaceuticals, I : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.